Atlas Trials

Using the Epitranscriptome to Diagnose and Treat Gliomas

Clinical trial NCT06575452 · RECRUITING

Trial details

NCT number
NCT06575452
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioma
Start date
2026-06-01
Primary completion
2028-05-01
Enrollment
228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.